<DOC>
	<DOCNO>NCT00036309</DOCNO>
	<brief_summary>The purpose study determine duloxetine effective compare placebo prevent recurrence major depressive disorder patient respond open-label duloxetine treatment .</brief_summary>
	<brief_title>Duloxetine Versus Placebo Prevention Relapse Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Signed informed consent Meet criterion major depressive disorder without psychotic feature . Have level understanding sufficient provide inform consent communicate investigator site personnel . Have least one major depressive episode prior one experience study entry . You reliable agree keep appointment clinic visit , test procedure require protocol . You treatment drug within last 30 day receive regulatory approval time study entry . Any woman pregnant breast feeding . If serious medical illness major depressive disorder . If previously participate clinical trial duloxetine . Any previous current diagnosis bipolar , schizophrenia , psychotic disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Diagnostic Statistical Manual Mental Disorders Fourth Edition-defined major depressive disorder without psychotic feature</keyword>
</DOC>